
Tezpire recommended in EU to treat chronic rhinosinusitis
AstraZeneca and Amgen’s drug Tezspire (tezepelumab) has been recommended for approval in the European Union for the treatment of adults with chronic rhinosinusitis with nasal polyps (CRSwNP). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on… Read More















